Leading firm in tackling infectious diseases, Open Orphan, has announced a new chief financial officer and executive director.
Stephen Pinkerton, 59, will tae over both roles at the contract research organisation, following the departure of Leo Toole as CFO.
Toole joined its board following the acquisition of hVIVO, helped improve its finances and then supported the company in the world’s first Covid characterisation study with the UK govt.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).